2-n-(4-(1-azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine has been researched along with Hypoglycemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Appel, NM; Hokari, M; Holman, GD; Koehler-Stec, EM; Maher, F; Oki, J; Simpson, IA; Smith, QR; Vannucci, SJ | 1 |
1 other study(ies) available for 2-n-(4-(1-azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine and Hypoglycemia
Article | Year |
---|---|
Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited.
Topics: Affinity Labels; Animals; Azides; Blood-Brain Barrier; Diabetes Mellitus, Experimental; Disaccharides; Glucose; Glucose Transporter Type 1; Glycosides; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Monosaccharide Transport Proteins; Photochemistry; Propylamines; Rats; Rats, Sprague-Dawley; Tritium | 1999 |